PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies
about
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studiesNew Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han populationThe renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.Effects of glycaemic management on diabetic kidney disease.The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic NephropathyPeroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.
P2860
Q26777994-00D98226-6573-4838-AD97-6BC5EB1E5B86Q35058771-A05463D5-B78E-423C-80DF-73270F242160Q35065022-AC93B350-C94D-49EE-BB7F-EB09004A6ECCQ35174597-BB041C35-74E2-4512-B4F0-D156BBC1452FQ35613936-ACE871AC-D720-4BBA-B9A9-ACE18C4390AEQ35976372-7859F9CC-2AEC-491D-BAAA-6D2A0FE351C1Q37590946-CF72A8F8-7C05-4E15-AD68-80B4609E6C0FQ37595726-40307D5E-73AC-4796-9B54-34EF311FA190Q37997004-483D66DA-5149-4B3B-8637-0CBD4C5F5C4FQ38019453-29A2AA14-509E-43A0-8438-9473CD0422F3Q38050731-C6AC9713-6DC4-4F68-9161-EAA5DDE121F5Q38121659-14B49296-366B-4706-A6CC-54B7971F83DAQ38254887-38E083D6-7A30-478C-89A3-7A2B61619D83Q39345204-6C5FE916-2C2E-4F4E-9002-D2AD8FAA3D21Q39937516-E8F6966A-7D7F-42B5-9615-6718C4D6F3C2Q41726958-652F1786-4BEA-4A6C-8400-8BCCE69F4E80Q42364753-8E5BF626-6D8F-4654-B839-7C710AE59461Q48141985-FB614609-17F2-4E50-ABE4-86747C7E3E63
P2860
PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies
description
article
@en
im April 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2011
@uk
name
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@en
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@nl
type
label
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@en
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@nl
prefLabel
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@en
PPAR 2 P12A polymorphism and a ...... alysis of case-control studies
@nl
P2093
P2860
P50
P356
P1476
PPARγ2 P12A polymorphism and a ...... alysis of case-control studies
@en
P2093
Eleonora Morini
Emanuela Lapice
Mauro Cignarelli
Olga Lamacchia
Rosa Di Paola
P2860
P304
P356
10.1093/NDT/GFR187
P407
P50
P577
2011-04-14T00:00:00Z